𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relationship between clinical staging of hepatocellular carcinoma and serum transforming growth factor β1

✍ Scribed by R. Pumpo; R. Cuomo; P. Esposito; D. Pomponi; G. Budillon; G. Capuano

Book ID
119629991
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
153 KB
Volume
32
Category
Article
ISSN
1590-8658

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transforming growth factor-β1 as a usefu
Transforming growth factor-β1 as a useful serologic marker of small hepatocellular carcinoma
✍ Byung-Cheol Song; Young-Hwa Chung; Jung A. Kim; Won-Beom Choi; Dong Dae Suh; Seu 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract ## BACKGROUND Although alpha‐fetoprotein (AFP) is a useful serologic marker of hepatocellular carcinoma (HCC), it has been reported insufficiently sensitive in detecting small HCCs. Plasma transforming growth factor‐β1 (TGFβ1) has been reported to be elevated in HCC patients compared w

Gene mutation of transforming growth fac
Gene mutation of transforming growth factor β1 type II receptor in hepatocellular carcinoma
✍ Keiko Furuta; Sachiko Misao; Kiyoshi Takahashi; Tsuneaki Tagaya; Yoshitaka Fukuz 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 146 KB 👁 1 views

Alteration of transforming growth factor beta1 (TGF-beta1) type II receptor (RII) appears to cause unresponsiveness to TGF-beta1 in tumorigenic cells. Defect in the mononucleotide repeat sequence, i.e., poly A region of TGF-beta1RII gene has been reported to be related to replication error-positive